Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013 Feb;6(1):94-103.
doi: 10.1007/s12265-012-9401-8. Epub 2012 Sep 7.

Next generation diagnostics in inherited arrhythmia syndromes : a comparison of two approaches

Affiliations
Comparative Study

Next generation diagnostics in inherited arrhythmia syndromes : a comparison of two approaches

James S Ware et al. J Cardiovasc Transl Res. 2013 Feb.

Abstract

Next-generation sequencing (NGS) provides an unprecedented opportunity to assess genetic variation underlying human disease. Here, we compared two NGS approaches for diagnostic sequencing in inherited arrhythmia syndromes. We compared PCR-based target enrichment and long-read sequencing (PCR-LR) with in-solution hybridization-based enrichment and short-read sequencing (Hyb-SR). The PCR-LR assay comprehensively assessed five long-QT genes routinely sequenced in diagnostic laboratories and "hot spots" in RYR2. The Hyb-SR assay targeted 49 genes, including those in the PCR-LR assay. The sensitivity for detection of control variants did not differ between approaches. In both assays, the major limitation was upstream target capture, particular in regions of extreme GC content. These initial experiences with NGS cardiovascular diagnostics achieved up to 89 % sensitivity at a fraction of current costs. In the next iteration of these assays we anticipate sensitivity above 97 % for all LQT genes. NGS assays will soon replace conventional sequencing for LQT diagnostics and molecular pathology.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Summary of target selection designs for the two target enrichment strategies. LQT long QT syndrome, bp base pairs
Fig. 2
Fig. 2
For a given target enrichment design, the percentage of bases reaching variant-calling criteria increases with increasing sequencing depth. For each sample, the percentage of target bases callable is plotted against the mean sequencing depth achieved for that sample. The Hyb-SR reached saturation when run with low multiplex, suggesting that a further increase in sequencing depth would not improve coverage. PCR-LR has not reached saturation: the dotted line shows maximum achievable coverage with a simulated sample generated by pooling reads from all samples, equivalent to ×660 depth
Fig. 3
Fig. 3
Coverage of the three genes most commonly causing long QT syndrome. Sequencing depth is plotted base by base across the protein-coding portions of three genes for a single sample sequenced on both platforms. Coverage varies widely for the Hyb-SR approach. PCR-LR yields more even coverage within amplicons, but there remains significant inter-amplicon variability. The first exons of KCNQ1 and KCNH2 are poorly captured by both techniques. The proportion covered sufficiently for variant calling ranges from 78 % (KCNH2, Hyb-SR) to 100 %
Fig. 4
Fig. 4
Target enrichment is strongly dependent on GC content. The distribution of GC content for the target region is shown, together with the GC content of bases consistently missed across all samples for each platform. Regions missed by Hyb-SR have a high GC content, while regions missed by PCR-LR may have a GC content at either extreme

References

    1. Moss AJ, Zareba W, Hall WJ, Schwartz PJ, Crampton RS, Benhorin J, Vincent GM, Locati EH, Priori SG, Napolitano C, Medina A, Zhang L, Robinson JL, Timothy K, Towbin JA, Andrews ML. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation. 2000;101(6):616–623. doi: 10.1161/01.CIR.101.6.616. - DOI - PubMed
    1. Schwartz PJ, Spazzolini C, Crotti L. All LQT3 patients need an ICD: true or false? Heart Rhythm. 2009;6(1):113–120. doi: 10.1016/j.hrthm.2008.10.017. - DOI - PubMed
    1. Vincent GM, Schwartz PJ, Denjoy I, Swan H, Bithell C, Spazzolini C, Crotti L, Piippo K, Lupoglazoff JM, Villain E, Priori SG, Napolitano C, Zhang L. High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment “failures”. Circulation. 2009;119(2):215–221. doi: 10.1161/CIRCULATIONAHA.108.772533. - DOI - PubMed
    1. Goldenberg I, Bradley J, Moss A, McNitt S, Polonsky S, Robinson JL, Andrews M, Zareba W. Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management. Journal of Cardiovascular Electrophysiology. 2010;21(8):893–901. - PMC - PubMed
    1. Liu JF, Moss AJ, Jons C, Benhorin J, Schwartz PJ, Spazzolini C, Crotti L, Ackerman MJ, McNitt S, Robinson JL, Qi M, Goldenberg I, Zareba W. Mutation-specific risk in two genetic forms of type 3 long QT syndrome. The American Journal of Cardiology. 2010;105(2):210–213. doi: 10.1016/j.amjcard.2009.08.676. - DOI - PMC - PubMed

Publication types

MeSH terms